Latest Derivatives News

James Bay Minerals reports exceptional metallurgical testwork results from its Independence Project in Nevada, confirming over 95% gold recovery using conventional processing methods. The findings highlight the project's potential for cost-effective development of its high-grade skarn resource.

GreenX Metals has revealed a substantial historical copper estimate at its Tannenberg project in Germany, alongside promising antimony-gold findings in Greenland and a major arbitration award against Poland.

Elixinol Wellness Limited (ASX – EXL) has launched a substantial options offer to placement investors and its lead manager, pending shareholder approval. The offer could reshape the company’s capital structure and potentially raise $4.4 million upon exercise.

Talga Group has made significant strides in Q1 FY2026 with key partnerships in the US and Germany, new patents, and a substantial Swedish government grant to advance its battery anode production.

Desane Group Holdings has declared a special 2 cent per share dividend following the sale of a key property in Lane Cove, signalling a direct return of capital to shareholders.

Althea Group Holdings reported a resilient September quarter with $5.4 million in receipts despite a major strike in British Columbia, bolstered by a $2.53 million capital raise and expansion in the US THC beverage market.

BluGlass Limited reports a robust project pipeline exceeding US$100 million, bolstered by initial orders from Collins Aerospace and Infleqtion Inc, alongside strategic board appointments and a $6 million R&D tax rebate.

Noxopharm Limited reports growing interest in its Sofra technology with new research collaborations and a safe, well-tolerated HERACLES trial of SOF-SKN. The company also secures funding extensions to support ongoing development.

Galileo Mining reports standout gold assays up to 13.7 g/t with significant palladium and platinum at its Norseman project, setting the stage for upcoming RC drilling to test promising bedrock targets.

Gateway Mining Ltd has initiated a large-scale aeromagnetic survey at its Glenburgh South project, while aggressive drilling continues at the flagship Yandal Gold Project, positioning the company for a pivotal exploration phase in 2026.

Tribune Resources reported steady gold output from its East Kundana Joint Venture and promising exploration results in Ghana, alongside a stronger cash position for the September quarter.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.